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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To determine the effect of patient information on antibiotic use in patients presenting to primary care settings with URTIs.
B A C K G R O U N D
Description of the condition
Respiratory infections are a heterogeneous group of diseases that
are traditionally divided into upper respiratory tract infections
(URTI) or lower respiratory tract infections (LRTI). These infec-
tions are typically defined as above or below the vocal folds, re-
spectively. URTI infections are commonly caused by viruses and
usually present with nasal stuffiness and discharge, sneezing, sore
throat and cough. Other symptoms include hoarseness, headache,
malaise and lethargy (Heikkinen 2003). Viral transmission is via
contact with bodily secretions or, less commonly, air transmis-
sion (via particle aerosols) (Heikkinen 2003). On average, chil-
dren are subjected to six to eight URTI per year; and adults, to two
to four per year (Heikkinen 2003). There is evidence to suggest
that antibiotics have little or no effect on common URTI includ-
ing acute otitis media (AOM) (Venekamp 2013), acute bronchi-
tis (Smith 2014), pharyngitis (Spinks 2013) and acute laryngitis
(Reveiz 2013). However, antibiotics continue to be prescribed for
URTI (Arnold 2005; Teng 2004). The likely mechanism is that
viruses infect endogenous (human) host cells and multiply within
these host cells, whereas bacteria multiply on an extracellular level
(Lee 2009). This is important because antibiotics target extracel-
lular bacterial multiplication, without damaging host cells, a phe-
nomenon known as selective toxicity (Lee 2009). Antibiotic ther-
apy cannot inhibit intracellular viral multiplication (Lee 2009).
We will not consider LRTI, such as pneumonia, in this review
because it is accepted practice to treat pneumonia with antibiotics.
Description of the intervention
As mentioned above, URTI are generally caused by viruses
(Heikkinen 2003), hence antibiotics have no effect but are still
prescribed and requested (Arnold 2005). Guidelines and educa-
tion alone have had little impact on the behaviour of both doctors
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and patients (Arnold 2005). However, some patient information
materials have had some effect, particularly when combined with
other interventions including delayed prescribing (where patients
are asked to wait a few days before considering using antibiotics)
(Spurling 2013) and behavioural interventions (Meeker 2014).
Written information may also form part of shared decision-mak-
ing interventions, public health campaigns or be given alongside
alternative symptomatic treatments for URTI. Given the breadth
of written information use, we anticipate that this review will in-
clude interventions that vary in content, style and quality. The
aim of this review is to explore the effect of written patient infor-
mation, displayed in a paper or electronic form, or both, and any
associated change in antibiotic use.
How the intervention might work
Knowledge of illness and treatment, beliefs about the benefits
or harms of a taking a treatment and expectations of treatment
outcome are known to influence medication-taking behaviour
(Jackson 2014; Michie 2011). Written information about antibi-
otics for acute respiratory infections may target these determinants
of antibiotic-taking behaviour and thereby, change patients’ an-
tibiotic use. Patients who receive antibiotics for the treatment of
an URTI are more likely to re-consult their doctor for further an-
tibiotics in the future (Moore 2009). If written information was
able to prevent patients taking antibiotics, this would potentially
interrupt this cycle, reduce reconsultation rates and subsequent
antibiotic use.
Why it is important to do this review
Respiratory tract infections are the most common reason for pa-
tients to consult primary care physicians (Francis 2009). About
20% of children who present with a respiratory tract infection
return during the same illness episode, even though most of these
visits are unnecessary (Francis 2009). Complications of respiratory
tract infections are rare, with little or no benefit from treatment
with antibiotics (Francis 2009). Antibiotics have common adverse
reactions (including rash, abdominal pain, diarrhoea and vom-
iting) (Berman 1997; Niemela 1999), and overprescribing may
contribute to community bacterial resistance (Costelloe 2010).
Therefore, tools to decrease inappropriate antibiotic prescribing
are needed in order to reduce adverse effects and the development
of community antibiotic resistance. Written information in paper
or electronic format, or both, used with or without a co-interven-
tion, is a simple, cheap and potentially effective means to improve
antibiotic prescribing for respiratory infections.
O B J E C T I V E S
To determine the effect of patient information on antibiotic use
in patients presenting to primary care settings with URTIs.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomised controlled trials (RCTs) that com-
pare information about antibiotics for acute respiratory infections
with no information. Trials that include information as the only
intervention and those that include information as an add-on in-
tervention will be included.
1. Information versus no information.
2. Information + intervention-X versus no information +
intervention-X (for example, where Intervention-X was delayed
prescribing or other intervention).
Wewill also include studies that compare information and another
intervention with a control (for example, usual care).
Types of participants
Patients of all ages defined as having a URTI. When children
are involved, the intervention may be directed to the parent/
guardian. We will exclude patients with LRTIs and those with
chronic lung conditions, such as chronic obstructive pulmonary
disease (COPD).
Types of interventions
Any written information, in both paper (for example, handout,
booklet, poster) or electronic (for example, video) format, given
to a patient with the aim of informing them about antibiotics
for acute respiratory infections, either as the main or as an add-
on intervention. This information must occur at the time of pre-
scribing, i.e. immediately prior or during. We will exclude studies
that offer information after prescribing, for example, pharmacists
educating via package inserts. Information must include details
about antibiotics for acute respiratory infections but it does not
have to be exclusive. Further, we will exclude interventions where
only verbal information is given.
Types of outcome measures
We will extract the following outcomes at the end of treatment
and end of follow-up. We will exclude studies that do not report
our primary outcome.
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Primary outcomes
1. Antibiotic use subsequent to the index consultation.
Secondary outcomes
1. Reconsultation.
2. Resolution of symptoms.
3. Patient knowledge about antibiotics for acute respiratory
infection.
4. Patient satisfaction with consultation.
5. Complications.
i) Adverse drug reaction due to the prescribed
antibiotics.
ii) Disease complications, for example, pneumonia or
mastoiditis.
*Note: If sufficient studies report ’time to resolution’ data, then
we will use this as a further secondary outcome, dividing the time
into three zones where the majority of studies can provide data.
Search methods for identification of studies
Electronic searches
We will search CENTRAL (latest issue), which contains the
Cochrane Acute Respiratory Infections Group’s Specialised Reg-
ister, MEDLINE (1946 to current date), EMBASE (2010 to cur-
rent date), CINAHL (1981 to current date), LILACS (1982 to
current date) and Web of Science (1955 to current date).
We will use the search strategy described in Appendix 1 to search
MEDLINE and CENTRAL. We will combine the MEDLINE
search with the Cochrane Highly Sensitive Search Strategy for
identifying randomised trials in MEDLINE (Lefebvre 2011). We
will adapt the search strategy to search EMBASE (Appendix 2),
CINAHL (Appendix 3), LILACS (Appendix 4) and Web of Sci-
ence (Appendix 5). We will not use any language or publication
restrictions.
Searching other resources
We will search the World Health Organization (WHO) In-
ternational Clinical Trials Registry Platform (ICTRP) and
www.clinicaltrials.gov for completed and ongoing trials. We will
review the reference lists of retrieved articles.
Data collection and analysis
Selection of studies
We will scan abstracts to identify if they might meet the inclusion
criteria. We will check the references of the selected trials to try
and identify any other articles. Two review authors (JOS, RH)
will independently apply the inclusion criteria to the full-text ar-
ticles. Two review authors (JOS, RH) will independently assess
the methodological quality of the included trials. We will resolve
disagreements by discussion.
Data extraction and management
We will extract data using a standardised form. We will include
the following information.
1. Age and gender of participants.
2. Number of participants.
3. Literacy level of participants (measured by highest level of
education or other methods employed by authors).
4. Description of intervention content, intensity (dose and
duration), mode of delivery and fidelity to intervention, where
available.
5. Antibiotic use.
6. Reconsultation rates.
7. Symptom resolution.
8. Complications such as adverse drug reactions and disease
complications.
As information contained in handouts could vary widely, we will
contact all trial authors directly to request copies of their informa-
tion handouts.
Assessment of risk of bias in included studies
Two review authors (JOS, RH) will independently assess the
methodological quality of each of the study trials using the ’Risk
of bias’ domains set out in the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011). The domains are as fol-
lows.
Selection bias
Random sequence generation: two review authors (JOS, RH) will
independently assess the method used to generate the allocation
sequence and whether this method was adequate to produce com-
parable groups.
Allocation concealment: two review authors (JOS, RH) will in-
dependently assess the method used to conceal the allocation se-
quence to determine whether intervention allocations could have
been foreseen in advance of, or during, enrolment.
Performance bias
Blinding of participants and personnel: two review authors (JOS,
RH) will independently assess the measures used, if any, to blind
study participants and personnel from knowledge of which in-
tervention a participant received. Further, the two review authors
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will search for any information stated as to whether the intended
blinding was effective.
Detection bias
Blinding of outcome assessment: two review authors (JOS, RH)
will independently assess the measures used, if any, to blind out-
come assessors from knowledge of which intervention a partic-
ipant received. Further, the two review authors (JOS, RH) will
search for any information relating to whether the intended blind-
ing was effective.
Attrition bias
Incomplete outcome data: two review authors (JOS, RH) will
independently assess the completeness of outcome data for each
main outcome, including attrition and exclusions from the analy-
sis. State whether attrition and exclusions were reported, the num-
bers in each intervention group (compared to total randomised
participants), reasons for attrition/exclusions where reported, and
any re-inclusions in analyses performed by review authors.
Reporting bias
Selective reporting: two review authors (JOS, RH) will indepen-
dently assess whether the possibility of selective outcome reporting
was examined by authors, and elaborate on what was found.
Other bias
Other sources of bias: two review authors (JOS, RH) will indepen-
dently assess whether authors state any important concerns about
bias not addressed in the other domains in the tool.
Two individual review authors (JOS, RH) will assess the quality
of the studies that meet the inclusion criteria. All review authors
(JOS, RH, PG) will then meet and resolve any disagreements. If
possible we will reconstruct intention-to-treat (ITT) analyses.
Measures of treatment effect
We will analyse data using RevMan 5.3 (RevMan 2014). As the
primary and secondary outcomes are dichotomous, we will use
risk ratios as the main measure of effect. We will also calculate
and report a number needed to treat to benefit (NNTB) for any
statistically significant outcomes.
Unit of analysis issues
Wewill use the patient as the unit of analysis. If there are includable
trials that use cluster designs, we will use an analysis adjusted for
within-cluster correlations.
Dealing with missing data
Wewill write to trial authors for clarification of anymissing data. If
a study outcome has more than 20%missing data, we will exclude
it from the primary analysis but include it in a sensitivity analysis.
Assessment of heterogeneity
We will assess the presence of heterogeneity in two steps. First,
we will assess obvious heterogeneity at face value by comparing
populations, settings, interventions and outcomes before deciding
whether it is appropriate to pool studies using a fixed-effect anal-
ysis, a random-effects analysis, or to not pool studies. If pooling
is done, we will assess statistical heterogeneity by means of the I2
statistic (Higgins 2011). Thresholds for the interpretation of the I
2 statistic can be misleading, since the importance of inconsistency
depends on several factors. We plan to use the guide to interpreta-
tion as outlined in the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011): 0% to 40%: might not be impor-
tant; 30% to 60%: may represent moderate heterogeneity; 50%
to 90%: may represent substantial heterogeneity; 75% to 100%:
considerable heterogeneity.
Assessment of reporting biases
We will search www.clinicaltrials.gov and other appropriate trials
databases for unpublished studies. We will contact trial authors to
request any unreported outcomes.
Data synthesis
We will analyse differences in antibiotic use via a risk ratio (RR)
with a 95% confidence interval (CI) calculated by the Mantel-
Haenszel method using a fixed-effect model.
Subgroup analysis and investigation of heterogeneity
We will conduct a subgroup analysis of the impact of patient
information based on whether or not delayed prescribing was also
used. That is, wewill group all trials bywhether they used a delayed
antibiotic prescription or not. Factorial studies (2 x 2 of delayed
prescription x handout) will contribute to both groups.
Sensitivity analysis
If a study outcome has more than 20% missing data, we will ex-
clude it from the primary analysis but include it in a sensitivity
analysis (see Dealing with missing data above). We plan to con-
duct sensitivity analyses to determine the robustness of results to
intervention intensity and fidelity.
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Appendix 1. MEDLINE (Ovid) search strategy
1 exp Respiratory Tract Infections/ (267266)
2 (respiratory adj3 infection*).tw. (28715)
3 (urti or lrti).tw. (840)
4 Otitis Media/ (14775)
5 otitis media.tw. (14693)
6 exp Sinusitis/ (14844)
7 sinusit*.tw. (10651)
8 (acute adj3 (rhinosinusit* or nasosinusit* or rhinit*)).tw. (563)
9 exp Pharyngitis/ (12604)
10 (pharyngit* or nasopharyngit* or tonsillit*).tw. (7293)
11 sore throat*.tw. (2858)
12 exp Laryngitis/ (4019)
13 laryngit*.tw. (1215)
14 croup.tw. (1010)
15 Cough/ (10867)
16 cough*.tw. (29125)
17 Common Cold/ (3273)
18 common cold*.tw. (2458)
19 coryza.tw. (350)
20 Influenza, Human/ (29323)
21 (influenza* or flu).tw. (73727)
22 Bronchitis/ (19330)
23 bronchit*.tw. (17051)
24 exp Bronchiolitis/ (5874)
25 bronchiolit*.tw. (6755)
26 or/1-25 (374954)
27 exp Anti-Bacterial Agents/ (481743)
28 antibiotic*.tw,nm. (210904)
29 27 or 28 (569485)
30 Patient Education as Topic/ (63802)
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31 Pamphlets/ (2825)
32 (pamphlet* or brochure* or leaflet* or booklet*).tw. (17230)
33 (flyer* or flier*).tw. (616)
34 information pack*.tw. (205)
35 information sheet*.tw. (472)
36 (cards or postcard*).tw. (7421)
37 (handout* or guidebook*).tw. (669)
38 (print* adj2 (material* or information* or guide or guides or instruction* or advice or advis*)).tw. (979)
39 or/30-38 (89662)
40 26 and 29 and 39 (267)
Appendix 2. EMBASE (Elsevier) search strategy
#51 #42 AND #50
#50 #45 NOT #49
#49 #46 NOT #48
#48 #46 AND #47
#47 ’human’/de
#46 ’animal’/de OR ’nonhuman’/de OR ’animal experiment’/de
#45 #43 OR #44
#44 random*:ab,ti OR placebo*:ab,ti OR crossover*:ab,ti OR ’cross over’:ab,ti OR trial:ti OR allocat*:ab,ti OR (doubl* NEXT/1
blind*):ab,ti
#43 ’randomized controlled trial’/exp OR ’single blind procedure’/exp OR ’double blind procedure’/exp OR ’crossover procedure’/exp
#42 #24 AND #27 AND #41
#41 #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40
#40 ’health literacy’/de
#39 ’consumer health information’/de
#38 ’information dissemination’/de
#37 ’persuasive communication’/de
#36 (patient* NEAR/3 (literatur* OR material* OR information* OR guide* OR guides OR instruction*)):ab,ti
#35 ((print* OR written OR text*) NEAR/3 (material* OR information* OR guide OR guides OR instruction* OR advice OR advis*
OR messag* OR note OR notes)):ab,ti
#34 handout*:ab,ti OR guidebook*:ab,ti
#33 card:ab,ti OR cards:ab,ti OR postcard*:ab,ti
#32 (information NEAR/2 (pack* OR sheet*)):ab,ti
#31 flyer*:ab,ti OR flier*:ab,ti
#30 pamphlet*:ab,ti OR brochure*:ab,ti OR leaflet*:ab,ti OR booklet*:ab,ti
#29 ’publication’/de
#28 ’patient education’/de
#27 #25 OR #26
#26 antibiotic*:ab,ti
#25 ’antibiotic agent’/exp
#24 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR
#17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23
#23 bronchit*:ab,ti OR bronchiolit*:ab,ti
#22 ’bronchitis’/exp
#21 influenza*:ab,ti OR flu:ab,ti
#20 ’influenza’/exp
#19 coryza:ab,ti
#18 ’common cold’/de OR ’common cold symptom’/de
#17 cough*:ab,ti
#16 ’coughing’/de
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#15 croup:ab,ti
#14 ((throat* OR ’middle ear’ OR tonsil* OR sinus* OR laryn* OR pharyn* OR bronch*) NEAR/3 (inflam* OR infect*)):ab,ti
#13 laryngit*:ab,ti
#12 ’laryngitis’/de
#11 ’sore throat’/de
#10 pharyngit*:ab,ti OR nasopharyngit*:ab,ti OR rhinopharyngit*:ab,ti OR tonsillit*:ab,ti
#9 ’pharyngitis’/exp
#8 (acute NEAR/3 (rhinosinusit* OR nasosinusit* OR rhinit*)):ab,ti
#7 sinusit*:ab,ti
#6 ’sinusitis’/exp
#5 ’otitis media’:ab,ti
#4 ’otitis media’/exp
#3 urti:ab,ti OR lrti:ab,ti
#2 (respiratory NEAR/3 infection*):ab,ti
#1 ’respiratory tract infection’/exp
Appendix 3. CINAHL (Ebsco) search strategy
S52 S42 and S51 S
S51 S43 or S44 or S45 or S46 or S47 or S48 or S49 or S50
S50 (MH “Quantitative Studies”)
S49 TI placebo* OR AB placebo*
S48 (MH “Placebos”)
S47 TI random* OR AB random*
S46 TI ((singl* or doubl* or tripl* or trebl*) W1 (blind* or mask*)) OR AB ((singl* or doubl* or tripl* or trebl*)W1 (blind* or mask*))
S45 TI clinic* trial* OR AB clinic* trial*
S44 PT clinical trial
S43 (MH “Clinical Trials+”)
S42 S25 and S28 and S41
S41 S29 or S30 or S31 or S32 or S33 or S34 or S35 or S36 or S37 or S38 or S39 or S40
S40 (MH “Information Literacy”)
S39 (MH “Communication”)
S38 (MH “Consumer Health Information”)
S37 TI (patient* N3 (literatur* or material* or information* or guide or guides or instruction*)) OR AB (patient* N3 (literatur* or
material* or information* or guide or guides or instruction*))
S36 TI ((print* or written or text*) N3 (material* or information* or guide or guides or instruction* or advice or advis* or messag* or
note or notes)) OR AB ((print* or written or text*) N3 (material* or
information* or guide or guides or instruction* or advice or advis* or messag* or note or notes))
S35 TI (handout* or guidebook*) OR AB (handout* or guidebook*)
S34 TI (card or cards or postcard*) OR AB (card or cards or postcard*)
S33 TI (information N2 (pack* or sheet*)) OR AB (information N2 (pack* or sheet*))
S32 TI (flyer* or flier*) OR AB (flyer* or flier*)
S31 TI (pamphlet* or brochur* or leaflet* or booklet*) OR AB (pamphlet* or brochur* or leaflet* or booklet*)
S30 (MH “Pamphlets”)
S29 (MH “Patient Education”)
S27 TI antibiotic* OR AB antibiotic*
S26 (MH “Antibiotics+”)
S25 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or
S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24
S24 TI (bronchit* or bronchiolit*) OR AB (bronchit* or bronchiolit*)
S23 (MH “Bronchitis+”)
S22 TI (influenza* or flu) OR AB (influenza* or flu)
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S21 (MH “Influenza+”)
S20 TI coryza OR AB coryza
S19 TI common cold* OR AB common cold*
S18 (MH “Common Cold”)
S17 TI cough* OR AB cough*
S16 (MH “Cough”)
S15 TI croup OR AB croup
S14 TI ((throat* or middle ear* or tonsil* or sinus* or laryn* or pharyn* or bronch*) N3 (inflam* or infect*)) OR AB ((throat* or
middle ear* or tonsil* or sinus* or laryn* or pharyn* or bronch*) N3 (inflam* or infect*))
S13 TI laryngit* OR AB laryngit*
S12 (MH “Laryngitis+”)
S11 TI sore throat* OR AB sore throat*
S10 TI ((pharyngit* or nasopharyngit* or rhinopharyngit* or tonsillit*)) OR AB ((pharyngit* or nasopharyngit* or rhinopharyngit*
or tonsillit*))
S9 (MH “Pharyngitis”)
S8 TI (acute N3 (rhinosinusit* or nasosinusit* or rhinit*)) OR AB (acute N3 (rhinosinusit* or nasosinusit* or rhinit*))
S7 TI sinusit* OR AB sinusit*
S6 (MH “Sinusitis+”)
S5 TI otitis media OR AB otitis media
S4 (MH “Otitis Media+”)
S3 TI ( urti or lrti ) OR AB ( urti or lrti )
S2 TI respiratory N3 infection* OR AB respiratory N3 infection*
S1 (MH “Respiratory Tract Infections+”)
Appendix 4. LILACS (BIREME) search strategy
(MH:“Anti-Bacterial Agents” OR Antibacterianos OR Antibacterianos OR antibiotic$ ORMH:D27.505.954.122.085$ OR Antibac-
terianos OR Antibióticos) AND (MH:“Patient Education as Topic” OR “Educación del Paciente” OR “Educação de Pacientes” OR
Pamphlets OR Folletos OR Folhetos OR Panfletos OR Libretes OR Livretos OR booklet$ OR brochur$ OR flyer$ OR flier$ OR
card OR cards OR postcard$ OR handout$ OR guidebook$ OR MH:“Consumer Health Information” OR “Información de Salud
al Consumidor” OR “Informação de Saúde ao Consumidor” OR MH:I02.233.332.186$ OR MH:N02.421.143.827.407.228$ OR
N02.421.726.407.228$ OR MH:“Persuasive Communication” OR “Comunicación Persuasiva” OR “Comunicação Persuasiva” OR
MH:“Information Dissemination” OR “Diseminación de Información” OR “Disseminação de Informação” OR “information sheet”
OR “information sheets” OR “information pack” OR “information packs” OR “information package” OR “printed information” OR
“printed instructions” OR “printed guides” OR “patient information” OR “patient instructions”)
Appendix 5. Web of Science (Thomson Reuters) search strategy
# 6 123 #5 AND #4
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All years
# 5 1,623,616 TOPIC: (random* or placebo* or ((singl* or doubl*) NEAR/1 blind*) or crossover* or “cross-over” or allocat*)
OR TITLE: (trial)
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All years
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(Continued)
# 4 282 #3 AND #2 AND #1
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All years
# 3 181,671 TOPIC: (pamphlet* or brochur* or leaflet* or booklet* or flyer* or flier* or (information NEAR/3 (pack* or
sheet*)) or card or cards or postcard* or handout* or guidebook* or ((print* or written or text*)NEAR/3 (material*
or information* or guide or guides or instruction* or advice or advis* or messag* or note or notes)) or ((patient*
or consumer*) NEAR/3 (literatur* or material* or information* or guide or guides or instruction*)))
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All years
# 2 225,746 TOPIC: (antibiotic* or anti-bacterial*)
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All years
# 1 218,318 TOPIC: ((respiratory NEAR/3 infection*) or urti or lrti or “otitis media” or sinusit* or (acute NEAR/1 (rhinosi-
nusit* or nasosinusit* or rhinit*)) or pharyngit* or nasopharyngit* or rhinopharyngit* or tonsillit* or “sore throat”
or “sore throats” or laryngit* or ((throat* or “middle ear” or tonsil* or sinus* or laryn* or pharyn* or bronch*)
NEAR/3 (infect* or inflam*)) or croup or cough* or “common cold” or “common colds” or coryza or influenza*
or flu or bronchit* or bronchiolit*)
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All years
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